International Clinical Trial: Study on the Predictive Value of Early Albumin-to-Fibrinogen Ratio (AFR) for Trauma-Induced Coagulopathy

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118492) titled 'Study on the Predictive Value of Early Albumin-to-Fibrinogen Ratio (AFR) for Trauma-Induced Coagulopathy' on Feb. 6.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Army Medical Center of PLA

Condition: Hemorrhagic Shock? Trauma-Induced Coagulopathy (TIC)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: Observation group:600;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=306064

Disclaimer: Curated by HT Syndication....